Good news for those with coronary artery disease. This study explored the prognostic value of three screening tests in patients with CAD – fasting glucose (FPG), 2-h postload glucose (2h-PG) from an oral glucose tolerance test (OGTT), and glycated hemoglobin A1c (HbA1c).
Results indicate that, in patients with CAD, 2h-PG can provide valuable prognostic information on the risk of future cardiovascular events. In addition, increases in HbA1c and 2h-PG can signal a greater risk for diabetes.
This study confirms, in a large cohort of people with CAD and without diabetes, the role of 2-hour glycemia during an oral glucose tolerance test (OGTT) as an independent risk factor for a future cardiovascular event.